ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Hypertension in Primary Care in Spain (TAPAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00868881
Recruitment Status : Completed
First Posted : March 25, 2009
Last Update Posted : July 13, 2009
Sponsor:
Information provided by:
AstraZeneca

Brief Summary:
Non-interventional,observational and retrospective study assessing the therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control.

Condition or disease
Hypertension

Study Type : Observational
Estimated Enrollment : 2160 participants
Time Perspective: Retrospective
Official Title: Treatment of Hypertension in Primary Care in Spain
Study Start Date : March 2009
Actual Study Completion Date : July 2009

Group/Cohort
1
Blood Pressure poorly controlled in the previous year and poorly controlled at the inclusion in the study
2
Blood Pressure poorly controlled in the previous year and well controlled at the inclusion in the study.
3
Blood Pressure well controlled in the previous year and well controlled at the inclusion in the study
4
Blood Pressure well controlled in the previous year and poorly controlled at the inclusion in the study
5
Blood Pressure well controlled in the previous year independently of the level of control at the inclusion.
6
Blood Pressure poorly controlled in the previous year independently of the level of control at the inclusion.



Primary Outcome Measures :
  1. Therapeutic and diagnostic attitude followed in primary care for a hypertensive patient depending on his degree of blood pressure control. [ Time Frame: 1 Year ]

Secondary Outcome Measures :
  1. Variation in the Percentage of patients with blood pressure controlled and not controlled during a year of follow-up. [ Time Frame: 1 Year ]
  2. Clinical profile and cardiovascular risk. [ Time Frame: 1 Year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients aged 18 years or older who has been diagnosed of primary hypertension and/or treated for hypertension.
Criteria

Inclusion Criteria:

  • Diagnosis of primary hypertension and/or treated for hypertension for one year or more
  • Clinical data of blood pressure measures for the last 12+/- 2 months before inclusion.

Exclusion Criteria:

  • Secondary Hypertension
  • Physical or psychological impairment for the understanding of the information to be given to the patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00868881


  Show 167 Study Locations
Sponsors and Collaborators
AstraZeneca

Responsible Party: Juan Carlos Palma, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00868881     History of Changes
Other Study ID Numbers: NIS-CES-DUM-2008/2
First Posted: March 25, 2009    Key Record Dates
Last Update Posted: July 13, 2009
Last Verified: July 2009

Keywords provided by AstraZeneca:
Hypertension
Therapeutic diagnostic attitude
Blood pressure

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases